(Q48819086)

English

A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors

scientific article published in January 1983

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

phase II clinical trial

0 references

author name string

L G Feun

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

D J Stewart

2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

M E Leavens

3

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

M A Burgess

4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

N Savaraj

5

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

R S Benjamin

6

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

G P Bodey

7

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

publication date

1 January 1983

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

45-48

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

Therapy of advanced gastrointestinal cancer with 1-3-bis-(2-chlorethyl)-l-nitrosourea (BCNU)

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy: the agents in current use

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-agent chemotherapy of brain tumors. A five-year review

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central nervous system leukemia and solid tumors of childhood. Treatment with 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU).

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of the nitrosoureas as a function of their lipid solubility in the chemotherapy of experimental rat brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00153640

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6678305

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48819086&oldid=2210960574"